Literature DB >> 17825578

The proinflammatory cytokines TNF-alpha and IL-1 beta impair economy of contraction in human myocardium.

U Hofmann1, S Heuer, K Meder, J Boehler, V Lange, T Quaschning, G Ertl, A Bonz.   

Abstract

Considerable experimental evidence has accumulated over the past years that proinflammatory cytokines, especially TNF-alpha and IL-1beta, impair myocardial function in different animal species. On the other hand, several prospective clinical trials studying TNF-alpha antagonist in patients with chronic heart failure were not able to demonstrate a benefit. As there might be a relevant species-related discrepancy, we intended to prove our previous results demonstrating impaired myocardial economy after exogenous administration of recombinant TNF-alpha in rat myocardium. In the present study, both TNF-alpha and IL-1beta not only revealed an immediate negative inotropic effect but also increased specific oxygen demand in human right-atrial myocardium. Enhanced oxygen consumption was not caused by an elevated basal metabolism but an impaired economy of contraction. Our results suggest that proinflammatory cytokines have a considerable effect on myocardial mechano-energetic parameters in human myocardium as well.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17825578     DOI: 10.1016/j.cyto.2007.07.185

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  13 in total

1.  Glucagon-like peptide-1 receptor agonist protects against hyperglycemia-induced cardiocytes injury by inhibiting high mobility group box 1 expression.

Authors:  Yuli Cai; Xiaorong Hu; Bo Yi; Ting Zhang; Zhongyuan Wen
Journal:  Mol Biol Rep       Date:  2012-10-07       Impact factor: 2.316

Review 2.  Vital signs as physiomarkers of neonatal sepsis.

Authors:  Brynne A Sullivan; Karen D Fairchild
Journal:  Pediatr Res       Date:  2021-09-07       Impact factor: 3.756

Review 3.  Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research.

Authors:  Joshua Remick; Vasiliki Georgiopoulou; Catherine Marti; Igho Ofotokun; Andreas Kalogeropoulos; William Lewis; Javed Butler
Journal:  Circulation       Date:  2014-04-29       Impact factor: 29.690

Review 4.  Biologics and heart failure in rheumatoid arthritis: are we any wiser?

Authors:  Maria I Danila; Nivedita M Patkar; Jeffrey R Curtis; Kenneth G Saag; Gim Gee Teng
Journal:  Curr Opin Rheumatol       Date:  2008-05       Impact factor: 5.006

5.  Intermittent levosimendan treatment in patients with severe congestive heart failure.

Authors:  Petri O Tuomainen; Jarkko Magga; Pekka Timonen; Kati Miettinen; Minna Kurttila; Esko Vanninen; Tomi Laitinen; Kirsi Timonen; Kari Punnonen; Ilkka Parviainen; Ari Uusaro; Olli Vuolteenaho; Matti Kivikko; Keijo Peuhkurinen
Journal:  Clin Res Cardiol       Date:  2013-03-17       Impact factor: 5.460

Review 6.  Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad.

Authors:  Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Mauro Galeazzi; Franco Laghi-Pasini
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

7.  Evaluation of Subtle Left Ventricular Systolic Dysfunction by Longitudinal Systolic Strain in Patients with Human Immunodeficiency Virus.

Authors:  Sukru Cetin; Alper Gündüz; Ayşe Şabablı Çetin; Ahmet Gurdal; Mutlu Çağan Sümerkan; Süleyman Sezai Yıldız; Nuray Uzun; Kadriye Orta Kilickesmez
Journal:  Acta Cardiol Sin       Date:  2018-07       Impact factor: 2.672

Review 8.  Physiological Changes and Pathological Pain Associated with Sedentary Lifestyle-Induced Body Systems Fat Accumulation and Their Modulation by Physical Exercise.

Authors:  Enrique Verdú; Judit Homs; Pere Boadas-Vaello
Journal:  Int J Environ Res Public Health       Date:  2021-12-17       Impact factor: 3.390

9.  Attenuation of inflammatory-mediated neurotoxicity by Saururus chinensis extract in LPS-induced BV-2 microglia cells via regulation of NF-κB signaling and anti-oxidant properties.

Authors:  Byung-Wook Kim; Sushruta Koppula; Shin-Young Park; Jin-Woo Hwang; Pyo-Jam Park; Ji-Hong Lim; Dong-Kug Choi
Journal:  BMC Complement Altern Med       Date:  2014-12-16       Impact factor: 3.659

10.  Coriandrum sativum attenuates microglia mediated neuroinflammation and MPTP-induced behavioral and oxidative changes in Parkinson's disease mouse model.

Authors:  Sushruta Koppula; Ramesh Alluri; Spandana Rajendra Kopalli
Journal:  EXCLI J       Date:  2021-04-28       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.